NASDAQ:TSHA

Taysha Gene Therapies Stock Forecast

etoro logo Buy TSHA
*Your capital is at risk
$6.50
+0.120 (+1.88%)
At Close: Jul 07, 2026
AI Analysis AI Analysis of TSHA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add TSHA to Watchlist?
Some Reasons Why To Add TSHA:
  • +168.6% price growth over the last year
  • High gross margin of 88.2%
  • Low bankruptcy risk (Altman Z-Score: 7.12)
PDF

Taysha Gene Therapies, Inc. stock price ended at $6.50 on Tuesday, after gaining 1.88%
(Updated on Jul 07, 2026)

Buy or Hold candidate since Jun 17, 2026 Gain 5.01%

The Taysha Gene Therapies, Inc. stock price gained 1.88% on the last trading day (Tuesday, 7th Jul 2026), rising from $6.38 to $6.50. During the last trading day the stock fluctuated 6.47% from a day low at $6.34 to a day high of $6.75. The price has risen in 6 of the last 10 days but is still down by -0.46% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately $23.92 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 8.61% during the next 3 months and, with a 90% probability hold a price between $5.40 and $8.01 at the end of this 3-month period.

TSHA Signals & Forecast

The Taysha Gene Therapies, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $6.56. On a fall, the stock will find some support from the long-term average at approximately $5.98. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, May 06, 2026, and so far it has fallen -6.88%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Taysha Gene Therapies, Inc. stock

Taysha Gene Therapies, Inc. finds support from accumulated volume at $6.34 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.410 between high and low, or 6.47%. For the last week, the stock has had daily average volatility of 5.79%.

Our recommended stop-loss: $6.12 (-5.82%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 41 days ago.)

Trading Expectations (TSHA) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect Taysha Gene Therapies, Inc. to open at $6.53, and during the day (based on 14 day Average True Range), to move between $6.29 and $6.71, which gives a possible trading interval of +/-$0.413 (+/-6.56%) up or down from last closing price. If Taysha Gene Therapies, Inc. takes out the full calculated possible swing range there will be an estimated 6.56% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $6.34 (2.46%) than the resistance at $6.67 (2.62%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Taysha Gene Therapies, Inc. stock A Buy?

Taysha Gene Therapies, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.688 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 8, 2026 - $6.53 ( 0.462%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

TSHA Performance

Trading levels for TSHA

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 6.94 6.77%
R2 6.78 4.36%
R1 6.69 2.87%
Price 6.50
S1 6.37 -1.95%
S2 6.28 -3.44%
S3 6.12 -5.85%

Accumulated Volume Support & Resistance Levels

Level Price
R3 6.81 4.77%
R2 6.73 3.54%
R1 6.67 2.62%
Price 6.50
S1 6.34 -2.46%
S2 6.21 -4.46%
S3 6.00 -7.69%

FAQ

What is the symbol for Taysha Gene Therapies, Inc. Stock and on which exchange is it traded?
The symbol for Taysha Gene Therapies, Inc. is TSHA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Taysha Gene Therapies, Inc. Stock?
Taysha Gene Therapies, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Taysha Gene Therapies, Inc. Stock?
Taysha Gene Therapies, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Taysha Gene Therapies, Inc. Stock.

What's the current price of Taysha Gene Therapies, Inc. Stock?
As of the end of day on the Jul 07, 2026, the price of an Taysha Gene Therapies, Inc. (TSHA) share was $6.50.

What is the 52-week high and low for Taysha Gene Therapies, Inc. Stock?
The 52-week high for Taysha Gene Therapies, Inc. Stock is $7.30 and the 52-week low is $2.33.

What is the market capitalization of Taysha Gene Therapies, Inc. Stock?
As of the Jul 07, 2026, the market capitalization of Taysha Gene Therapies, Inc. is 1.626B.

When is the next earnings date for Taysha Gene Therapies, Inc.?
The upcoming earnings date for Taysha Gene Therapies, Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT TAYSHA GENE THERAPIES, INC.
Taysha Gene Therapies
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN1 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 foe the treatment of ...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
16.27% Jun 29
OSIS
$218.29
0.197% Jun 26
NMRK
$15.02
4.19% Jun 24
X
XMAX
$8.34
4.56% Jun 24
TTEK
$28.04
10.31% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE